Tumour devascularisation as a potential immunotherapeutic strategy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F19%3A00506201" target="_blank" >RIV/68378050:_____/19:00506201 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/19:10394164 RIV/00216208:11130/19:10394164 RIV/00064203:_____/19:10394164
Result on the web
<a href="https://www.tandfonline.com/doi/full/10.1080/15384101.2019.1593649" target="_blank" >https://www.tandfonline.com/doi/full/10.1080/15384101.2019.1593649</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/2162402X.2018.1526614" target="_blank" >10.1080/2162402X.2018.1526614</a>
Alternative languages
Result language
angličtina
Original language name
Tumour devascularisation as a potential immunotherapeutic strategy
Original language description
Complete tumour devascularisation (CTD) is a surgical technique which entails the complete disruption by ligation or cutting of afferent and efferent tumour vasculature which remains in situ. In some animal models, CTD induces immune responses that lead to regression of distant metastases and protective immunity.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30102 - Immunology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Oncoimmunology
ISSN
2162-402X
e-ISSN
—
Volume of the periodical
8
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
6
Pages from-to
e1526614
UT code for WoS article
000457342800031
EID of the result in the Scopus database
—